Last updated: 2026-09-23 17:58:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Bristol-Myers Squibb Co. (BMY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $61.60, with a market capitalisation of $127.91B and a P/E ratio of 13.70. Over the past 52 weeks, its price has ranged from $42.52 to $68.64. This page covers its latest market performance, valuation, price trends and company information.
$127.91B | |
$62.31 | |
$81.44 | |
$16.00 | |
$62.25 | |
4.17M | |
11.12M | |
13.70 | |
$68.64 | |
$42.52 | |
4.01% | |
-- |
Bristol-Myers Squibb Co. (BMY) is currently trading at $61.60 as of 2026-09-23 17:42:56, down 1.05% ($0.65) from the previous close of $62.25
During today's regular trading session, BMY has traded between $16.00 and $81.44, with a trading volume of 4.17M shares. The current price is near the upper end of today's range.
Over the past seven days, Bristol-Myers Squibb Co. (BMY) moved from $64.10 to $61.60, representing a decline of 3.90% ($2.50).
The stock traded between $61.47 and $65.29 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 13.93 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 73.0%
BMY is currently trading at $61.60, placing it 73.0% of the way from its 52-week low of $42.52 to its 52-week high of $68.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 32500 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Bristol-Myers Squibb Co. (BMY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.